---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-120129"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:37:12.692250+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# China Pharma subsidiary to acquire captopril microcapsule patent for $6.3M in stock

## Summary
- Hainan Helpson subsidiary to receive Captopril microcapsule invention patent and preparation method from Lijie Tang.
- Transfer price of $6.3 million paid via 3,500,000 shares of CPHI common stock at $1.80 per share.
- Transferor to provide technical services including product R&D, registration materials, and application support.
- Shares issued as unregistered securities under Regulation S to a non-U.S. person.

## SEC filing metadata
- accession: 0001213900-25-120129
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390025120129/0001213900-25-120129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390025120129/ea026901601-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-120129
- JSON: https://secwatch.observer/filing/0001213900-25-120129.json
- Plain text: https://secwatch.observer/filing/0001213900-25-120129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.